Marbe Pharma
Marbella · Since 2018

Strategic supply chain partner for heparin and critical APIs

We secure reliable, multi-source and technically supervised supply of heparin, glycosaminoglycans and critical active pharmaceutical ingredients for the pharmaceutical industry.

Discuss your supply Heparin and derivatives
40+
years of experience in heparin production, analytical control and GMP
HOR → API
full coverage of the heparin value chain
GDP
certified distribution of APIs for human use
Value proposition

We reduce risk across your supply chain

Supply chains for animal-derived APIs are concentrated and exposed. We work to make yours resilient.

  1. Diversification beyond Asia

    Access to qualified alternative sources to reduce geographic concentration.

  2. Less single-supplier dependency

    Multi-source structures that protect the continuity of your production.

  3. Lower regulatory risk

    Technical and regulatory coordination at every link, with a GMP mindset.

  4. Strategic, not transactional

    Long-term agreements built on cooperation and mutual benefit.

Business lines

Specialised where technical knowledge makes the difference

Core business

Heparin and derivatives

Heparin on Resin (HOR), crude heparin, unfractionated injectable heparin and glycosaminoglycans: supply and production technology.

Explore heparin and derivatives
Supply

Critical APIs and other products

Critical APIs, high-lipase pancreatin, niche animal by-products, in-licensing support and representation in Spain.

Explore products and services
Consulting

Technical services

Plant design, technology transfer, training in production, analysis and GMP, and quality improvement for producers.

Explore technical consulting
From raw material to API

We know every stage of heparin

Our expertise covers the whole chain, from mucosa collection to the injectable heparin that is also the basis for low molecular weight heparins.

  1. 01

    Porcine intestinal mucosa

    Collection of the raw material at source.

  2. 02

    Heparin on Resin (HOR)

    Adsorption on cationic resin: first intermediate.

  3. 03

    Crude heparin

    Further physico-chemical purification.

  4. 04

    Injectable heparin

    Unfractionated API, basis for LMWH.

How we work

A structured partnership model

  1. 01

    Strategic representation

    We act as a commercial and technical extension of our partners.

  2. 02

    Exclusive agreements

    Solid relationships that give both sides stability.

  3. 03

    Structured distribution

    Logistics and documentation in line with GDP.

  4. 04

    Technical and regulatory coordination

    Expert oversight of quality, analysis and compliance.

  5. 05

    Win-win cooperation

    Shared goals and long-term mutual benefit.

Expertise

Technical depth that sets us apart

Our technical partner, Mr. Hitendra Mehta, brings more than 40 years at Scientific Protein Laboratories (USA) in injectable heparin production, analysis, quality control and GMP. A level of know-how rarely found in API trading.

Meet the team
  • Dr. Julio Ortega
    Dr. Julio Ortega CEO and founding partner
  • HM
    Mr. Hitendra Mehta Strategic technical partner
Vision 2026+

Building a more resilient European supply chain

  • Consolidate a European footprint in heparin, GAGs and animal-derived APIs.
  • Establish long-term exclusive partnerships.
  • Develop upstream integration through selected joint ventures.
  • Build resilient, multi-source supply chains.

Looking for a reliable partner for heparin or critical APIs?

Tell us about your supply needs or technical project. We will reply personally.

Contact us